Feb. 19 at 8:56 PM
$LUNG 10
About Pulmonx | Maker of the Zephyr Valve for Emphysema
The Pulmonx Chartis Pulmonary Assessment System has received multiple FDA 510(k) clearances for assessing collateral ventilation in patients with severe emphysema, crucial for determining suitability for the Zephyr Endobronchial Valve. Key clearances include the Chartis Console and catheters (e.g., K111764, K180011, K222340).
U.S. Food and Drug Administration (.gov)
U.S. Food and Drug Administration (.gov)
+4
